Up a level |
(2016) Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven (TM)) and Activated Prothrombin Complex Concentrates (FEIBA (TM)) to Treat Hemophilia A Patients with Inhibitors in Iran. Iranian Journal of Pharmaceutical Research. pp. 669-677. ISSN 1735-0328
(2016) Health care resource utilization and cost of care for haemophilia A and B patients in Iran. Transfusion and Apheresis Science. pp. 122-126. ISSN 1473-0502